Diana Smith Hill (@helobuff)

Alpha-Gal Investigative Report- LYME DISEASE MARBURG COVID AND EBOLA DARPA’s weaponized ticks containing radioisotopes, deadly parasites and bacteria. A recent CDC report estimates that a whopping 24% of adults in five high-risk states—Arkansas, Kentucky, Missouri, Tennessee, and Virginia—carry alpha-gal antibodies, indicating exposure to the sugar molecule that triggers alpha-gal syndrome. Radioactive ticks have been used in two distinct contexts: scientific ecological studies involving radioisotope tagging to track movement, and alleged Cold War experiments where ticks were reportedly made radioactive to study dispersal or potentially used as biological weapons. #ticks #alphagal #gainoffunction #attackonthepeople THIS IS AN ILLEGAL ATTACK ON THE PEOPLE OF THE UNITED STATES IF THEY DO NOT RELEASE THE CURE (WHICH THEY HAVE BECAUSE THEY DID THE GAIN OF FUNCTION ON IT_ THEY ALWAYS REVERSE ENGINEER IT_ THEN THE PEOPLE WILL FILE A CLASS ACTION LAWSUIT AGAINST THE GOVT FOR ATTACKING THE VERY PEOPLE WHO FUND THEM. #ERINBROKOVITCH #LAWSUIT #TICKS #ALPHAGAL #LYME #DISEASES The Defense Advanced Research Projects Agency (DARPA) and the U.S. military’s bioweapons program, specifically at Rocky Mountain Laboratories, historically investigated the potential to enhance biological agents through radiation and microbial exposure to increase their lethality and resistance to pharmaceutical treatment. This lab also focuses on severe infectious diseases such as Ebola, Marburg, and COVID-19. Declassified documents and investigations suggest that tick specimens were altered through radiation and microbial exposure prior to potential release, prompting allegations that these methods contributed to the spread of Lyme disease in the U.S. The U.S. government holds patents on Lyme disease diagnostics and treatments (including vaccines), primarily managed by agencies such as the National Institutes of Health (NIH) and the Department of Energy (DOE). Research funded by the DOE Office of Biological and Environmental Research and the NIH led to U.S. Patent 7,179,448 (issued 2007). While assigned to Brookhaven Science Associates (operated for the DOE), this patent covers chimeric proteins developed by scientists at Brookhaven National Laboratory and Stony Brook University for use in genetically engineered proteins (spike protein) in vaccines and diagnostic tests. https://drloveariyana.substack.com/p/darpa-ticks-insert-radioisotopes?utm_source=cross-post&publication_id=2333233&post_id=202911864&utm_campaign=2333233&isFreemail=true&r=o3qy&triedRedirect=true&utm_medium=email